Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 17;12(10):1729.
doi: 10.3390/jpm12101729.

IL-2 and IL-1β Patient Immune Responses Are Critical Factors in SARS-CoV-2 Infection Outcomes

Shereen Fawzy  1 , Mesaik M Ahmed  1 , Badr A Alsayed  2 , Rashid Mir  3 , Dnyanesh Amle  4
Affiliations

IL-2 and IL-1β Patient Immune Responses Are Critical Factors in SARS-CoV-2 Infection Outcomes

Shereen Fawzy et al. J Pers Med. .

Abstract

Background: Immune dysregulation has been linked to morbidity and mortality in COVID-19 patients. Understanding the immunology of COVID-19 is critical for developing effective therapies, diagnostics, and prophylactic strategies to control the disease.

Aim: The aim of this study was to correlate cytokine and chemokine serum levels with COVID-19 disease severity and mortality.

Subjects and methods: A total of 60 hospitalized patients from the Tabuk region of Saudi Arabia with confirmed COVID-19 were included in the study. At hospital admission, the IL-1 β, IL-2, IL-8, IL-10, LT-B4, and CCL-2 serum levels were measured. The cytokine levels in COVID-19 patients were compared to the levels in 30 healthy matched control subjects.

Results: The IL-1 β, IL-2, LTB-4, CCL-2, and IL-8 levels (but not IL-10) were significantly higher in all COVID-19 patients (47 survivors and 13 non-survivors) compared with the levels in the healthy control group. In the non-survivor COVID-19 patients, patients' age, D-dimer, and creatinine kinase were significantly higher, and IL-1 β, IL-2, and IL-8 were significantly lower compared with the levels in the survivors.

Conclusion: Mortality rates in COVID-19 patients are associated with increased age and a failure to mount an effective immune response rather than developing a cytokine storm. These results warrant the personalized treatment of COVID-19 patients based on cytokine profiling.

Keywords: COVID-19; IL-1β; IL-2; cytokine storm; immune response; morbidity; mortality.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Parameters of the high-value predictors of mortality.
Figure 2
Figure 2
Parameters of the low-value predictors of mortality.
See this image and copyright information in PMC

References

    1. [(accessed on 20 July 2022)]. Available online: https://www.worldometers.info/coronavirus/country/saudi-arabia/
    1. Zhou X., Ye Q. Cellular Immune Response to COVID-19 and Potential Immune Modulators. Front. Immunol. 2021;12:646333. doi: 10.3389/fimmu.2021.646333. - DOI - PMC - PubMed
    1. Khosroshahi L.M., Rokni M., Mokhtari T., Noorbakhsh F. Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview. Int. Immunopharmacol. 2021;93:107364. doi: 10.1016/j.intimp.2020.107364. - DOI - PMC - PubMed
    1. Darif D., Hammi I., Kihel A., Saik I.E.I., Guessous F., Akarid K. The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong? Microb. Pathog. 2021;153:104799. doi: 10.1016/j.micpath.2021.104799. - DOI - PMC - PubMed
    1. Costela-Ruiz V.J., Illescas-Montes R., Puerta-Puerta J.M., Ruiz C., Melguizo-Rodríguez L. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. 2020;54:62–75. doi: 10.1016/j.cytogfr.2020.06.001. - DOI - PMC - PubMed

LinkOut - more resources